Literature DB >> 9334527

A comparative study of defense styles of bulimic, anorexic and normal females.

S Tordjman1, C Zittoun, P Ferrari, M Flament, P Jeammet.   

Abstract

We have compared the defense styles of anorexic (N = 41), bulimic (N = 37) and normal females (N = 72) living in Paris, using the Bond Defense Style Questionnaire relating to 17 defenses: sublimation, anticipation, suppression, undoing, idealization, reaction formation, projection, passive aggression, acting out, isolation, devaluation, autistic fantasy, denial, displacement, dissociation, splitting and somatization. The objective of this study was to better understand the personality structure in terms of psychological defenses of adolescent girls and young women suffering from anorexia or bulimia nervosa (DSM-III-R). Data showed significant differences of psychological functioning between control subjects and eating disorder subjects, particularly for the projection, undoing and sublimation defenses. Anorexics differed from the bulimic females only on the passive aggression, isolation and devaluation defenses. These data are discussed in relation to the hypothesis that anorexics and bulimics can be situated on the same continuum ranging from normal to eating disorders with certain common psychological features as risk factors shared by the eating disorder females.

Entities:  

Mesh:

Year:  1997        PMID: 9334527

Source DB:  PubMed          Journal:  Isr J Psychiatry Relat Sci        ISSN: 0333-7308            Impact factor:   0.481


  2 in total

1.  Development and Validation of a Measure of Passive Aggression Traits: The Passive Aggression Scale (PAS).

Authors:  Young-Ok Lim; Kyung-Hyun Suh
Journal:  Behav Sci (Basel)       Date:  2022-08-08

2.  The role of eating disorders features, psychopathology, and defense mechanisms in the comprehension of orthorexic tendencies.

Authors:  Giulia Costanzo; Daniela Marchetti; Giovanna Manna; Maria Cristina Verrocchio; Giorgio Falgares
Journal:  Eat Weight Disord       Date:  2022-06-01       Impact factor: 3.008

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.